AAAAAA
Results: 1-25/27
Authors:
Warkentin, TE
Citation: Te. Warkentin, Heparin-induced thrombocytopenia: Yet another treatment paradox?, THROMB HAEM, 85(6), 2001, pp. 947-949
Authors:
Warkentin, TE
Kelton, JG
Citation: Te. Warkentin et Jg. Kelton, Heparin-induced thrombocytopenia - Reply, N ENG J MED, 345(8), 2001, pp. 619-620
Authors:
Warkentin, TE
Kelton, JG
Citation: Te. Warkentin et Jg. Kelton, Temporal aspects of heparin-induced thrombocytopenia, N ENG J MED, 344(17), 2001, pp. 1286-1292
Authors:
Warkentin, TE
Citation: Te. Warkentin, Argatroban - A viewpoint, DRUGS, 61(4), 2001, pp. 523-523
Authors:
Hirsh, J
Warkentin, TE
Shaughnessy, SG
Anand, SS
Halperin, JL
Raschke, R
Granger, C
Ohman, EM
Dalen, JE
Citation: J. Hirsh et al., Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety, CHEST, 119(1), 2001, pp. 64S-94S
Authors:
Moore, JC
Hayward, CPM
Warkentin, TE
Kelton, JG
Citation: Jc. Moore et al., Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders, BLOOD, 98(6), 2001, pp. 1842-1846
Authors:
Warkentin, TE
Dunn, GL
Cybulsky, IJ
Citation: Te. Warkentin et al., Off-pump coronary artery bypass grafting for acute heparin-induced thrombocytopenia, ANN THORAC, 72(5), 2001, pp. 1730-1732
Authors:
Warkentin, TE
Citation: Te. Warkentin, Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis, ANN INT MED, 135(8), 2001, pp. 589-593
Authors:
Warkentin, TE
Kelton, JG
Citation: Te. Warkentin et Jg. Kelton, Delayed-onset heparin-induced thrombocytopenia and thrombosis, ANN INT MED, 135(7), 2001, pp. 502-506
Authors:
Warkentin, TE
Citation: Te. Warkentin, Heparin-induced thrombocytopenia and its treatment, J THROMB TH, 9(1), 2000, pp. S29-S35
Authors:
Warkentin, TE
Citation: Te. Warkentin, Laboratory testing for heparin-induced thrombocytopenia, J THROMB TH, 10, 2000, pp. S35-S45
Authors:
Ray, EK
Warkentin, TE
O'Hoski, PL
Gregor, P
Citation: Ek. Ray et al., Delayed onset of life-threatening immune hemolysis after perioperative antimicrobial prophylaxis with cefotetan, CAN J SURG, 43(6), 2000, pp. 461-462
Authors:
Warkentin, TE
Sheppard, JAI
Horsewood, P
Simpson, PJ
Moore, JC
Kelton, JG
Citation: Te. Warkentin et al., Impact of the patient population on the risk for heparin-induced thrombocytopenia, BLOOD, 96(5), 2000, pp. 1703-1708
Authors:
Hughes, M
Hayward, CPM
Warkentin, TE
Horsewood, P
Chorneyko, KA
Kelton, JG
Citation: M. Hughes et al., Morphological analysis of microparticle generation in heparin-induced thrombocytopenia, BLOOD, 96(1), 2000, pp. 188-194
Authors:
Warkentin, TE
Sheppard, JI
Citation: Te. Warkentin et Ji. Sheppard, Generation of platelet-derived microparticles and procoagulant activity byheparin-induced thrombocytopenia IgG/serum and other IgG platelet agonists: a comparison with standard platelet agonists, PLATELETS, 10(5), 1999, pp. 319-326
Authors:
Warkentin, TE
Sikov, WM
Lillicrap, DP
Citation: Te. Warkentin et al., Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia, AM J HEMAT, 62(1), 1999, pp. 44-48
Authors:
Warkentin, TE
Citation: Te. Warkentin, Heparin-induced thrombocytopenia: A clinicopathologic syndrome, THROMB HAEM, 82(2), 1999, pp. 439-447
Authors:
Warkentin, TE
Barkin, RL
Citation: Te. Warkentin et Rl. Barkin, Newer strategies for the treatment of heparin-induced thrombocytopenia, PHARMACOTHE, 19(2), 1999, pp. 181-195
Authors:
Warkentin, TE
Citation: Te. Warkentin, Heparin-induced thrombocytopenia: A ten-year retrospective, ANN R MED, 50, 1999, pp. 129-147
Authors:
Warner, MN
Pavord, S
Moore, JC
Warkentin, TE
Hayward, CP
Kelton, JG
Citation: Mn. Warner et al., Serum-induced platelet procoagulant activity: An assay for the characterization of prothrombotic disorders, J LA CL MED, 133(2), 1999, pp. 129-133
Authors:
Hughes, M
Hayward, CPM
Horsewood, P
Warkentin, TE
Kelton, JG
Citation: M. Hughes et al., Measurement of endogenous and exogenous alpha-granular platelet proteins in patients with immune and nonimmune thrombocytopenia, BR J HAEM, 106(3), 1999, pp. 762-770
Authors:
Warner, MN
Moore, JC
Warkentin, TE
Santos, AV
Kelton, JG
Citation: Mn. Warner et al., A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura, BR J HAEM, 104(3), 1999, pp. 442-447
Authors:
Warkentin, TE
Citation: Te. Warkentin, Clinical presentation of heparin-induced thrombocytopenia, SEM HEMATOL, 35(4), 1998, pp. 9-16
Authors:
Warkentin, TE
Citation: Te. Warkentin, Limitations of conventional treatment options for heparin-induced thrombocytopenia, SEM HEMATOL, 35(4), 1998, pp. 17-25
Authors:
Ling, E
Warkentin, TE
Citation: E. Ling et Te. Warkentin, Intraoperative heparin flushes and subsequent acute heparin-induced thrombocytopenia, ANESTHESIOL, 89(6), 1998, pp. 1567-1569